Trial site
Affiliated Cancer Hospital of Harbin Medical University
- 18running trials
- 3closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer5 trials
- Metastatic breast cancer5 trials
- Lung cancer4 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Mantle cell lymphoma1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 311 trials
- Phase 1/24 trials
- Phase 23 trials
- Phase 12 trials
- Status
- Active, not recruiting6 trials
- Not yet recruiting6 trials
- Recruiting6 trials
- Terminated3 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.7 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.4 trials
- Amgen2 trials
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.2 trials
- Abbisko Therapeutics Co, Ltd1 trial
- and 5 more
Running trials
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Recruiting
Active, not recruiting
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
Recruiting
Active, not recruiting
Active, not recruiting
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer3 recruiting
- Metastatic breast cancer3 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Terminated
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Terminated
Site data: ClinicalTrials.govUpdated 14 Nov 2026